Metformin Hydrochloride Generics [uk]

Metformin Hydrochloride, the active ingredient in Metformin Hydrochloride Generics [uk], is a biguanide presented as an oral tablet for oral use. It is used to lower elevated blood glucose levels in adults with type 2 diabetes and in certain off‑label situations.

GNH USA supplies Metformin Hydrochloride Generics [uk] as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Hydrochloride is an oral biguanide indicated for disorders of glucose metabolism.

- Type 2 diabetes mellitus: improves glycaemic control by reducing hepatic glucose output and enhancing insulin sensitivity. - Gestational diabetes (off‑label): may help control maternal blood glucose during pregnancy. - Polycystic ovary syndrome (off‑label): can improve insulin resistance and assist with menstrual regulation.

Metformin Hydrochloride may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or diarrhoea. - Metallic taste in the mouth. - Decreased appetite. - Mild headache. - Weight loss.

Serious or Rare Side Effects: - Lactic acidosis: a rare but potentially fatal metabolic disturbance. - Severe skin reactions such as Stevens‑Johnson syndrome. - Hepatic dysfunction. - Vitamin B12 deficiency with long‑term use. - Hypoglycaemia when combined with other glucose‑lowering agents.

When prescribing Metformin Hydrochloride, clinicians should consider several safety aspects.

- Renal function: avoid use in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²). - Hepatic disease: use cautiously in those with liver dysfunction. - Cardiovascular status: monitor in patients with unstable heart failure. - Alcohol intake: advise limiting alcohol to reduce lactic acidosis risk. - Pregnancy and lactation: assess risk‑benefit before use. - Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture and direct sunlight.

Metformin Hydrochloride can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure, increasing lactic acidosis risk. - Cimetidine: can raise metformin plasma concentrations. - Certain antiretrovirals (e.g., dolutegravir): may increase metformin exposure.

Moderate Interactions (Monitor Closely): - Diuretics: may affect renal clearance of metformin. - Beta‑blockers: can mask hypoglycaemia symptoms. - ACE inhibitors or ARBs: monitor renal function when combined. - Thyroid hormones: may enhance glucose‑lowering effect. - Alcohol: potentiates lactic acidosis risk.